SCHEMBL9528033

SCHEMBL9528033

CCCCCc1nc(CCCCC)n(C)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT1 Q96EB6 1/20 0.44
HTT P42858 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
KDM4E B2RXH2 2/20 0.36
NPC1 O15118 1/20 0.36
TDP2 O95551 1/20 0.36
ABL1 P00519 1/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
THRB P10828 1/20 0.36
MPI P34949 1/20 0.36
RECQL P46063 1/20 0.36
RAB9A P51151 1/20 0.36
DUSP3 P51452 1/20 0.36
GALK1 P51570 1/20 0.36
BLM P54132 1/20 0.36
CASP9 P55211 1/20 0.36
CASP6 P55212 1/20 0.36
RIN1 Q13671 1/20 0.36
CASP8 Q14790 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8259928 0.94 SIRT1 (0.49) SIRT1HTTSMN1; SMN2KDM4ENPC1
SCHEMBL13585976 0.81 AGTR1 (0.39) SIRT1CYP1A2CYP2C9CYP2C19
SCHEMBL9528025 0.78 XDH (0.33) SIRT1HTTSMN1; SMN2KDM4EKCNH2
SCHEMBL8109107 0.73 ADORA3 (0.41) SIRT1HTTSMN1; SMN2KDM4ENPC1
SCHEMBL14394352 0.72 AGTR1 (0.41) SIRT1
SCHEMBL9529988 0.71 NR1H3 (0.54) NPC1RAB9AADORA3ADORA2AADORA1
SCHEMBL92739 0.70 KCNH2 (0.46) SMN1; SMN2THRBL3MBTL1KCNH2GPR84
SCHEMBL18529395 0.70 KCNH2 (0.36) KCNH2XDHCNR1CNR2
SCHEMBL13714538 0.69 SIRT1 (0.36) SIRT1XDHCNR1CNR2ALDH1A1
SCHEMBL7711334 0.68 KCNH2 (0.50) SMN1; SMN2KDM4ETHRBKCNH2GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0527851-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-02-24 EP disclosed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO disclosed